EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways

Xiaotian Han, Lingfang Xia, Yong Wu, Xiaojun Chen, Xiaohua Wu

Oncogene · 18.04.2025 · 44 (14) · 968-982

DOI: 10.1038/s41388-024-03260-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncogene, online erschienen am 15.01.2025. Verfasst von Xiaotian Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, RNA, Circular, Interleukin-6, Proto-Oncogene Proteins c-ets. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China (National Science Foundation of China).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, circRNAs have garnered increasing attention for their role in cervical cancer. However, the functions of many newly identified circRNAs remain unclear and require further exploration. In this study, we investigated the expression and oncogenic potential of the novel circRNA circSTX6 in cervical cancer. Our findings revealed that circSTX6 is highly expressed in cervical cancer (CC) and is significantly associated with poor patient prognosis, promoting cell survival, proliferation, invasion, and migration. Mechanistically, circSTX6 enhances the stability of the transcription factor SPI1 by binding to it, thereby upregulating IL6 transcription and activating the JAK2/STAT3 signaling pathway. Additionally, METTL3-mediated N6-methyladenosine (m6A) modification stabilizes circSTX6 through recognition by YTHDC1, forming a positive feedback regulatory loop among METTL3, circSTX6, and SPI1. These findings not only deepen our understanding of the biological mechanisms underlying CC but also highlight circSTX6 as a potential target for molecular therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsRNA, CircularInterleukin-6Proto-Oncogene Proteins c-etsHumansFemaleSTAT3 Transcription FactorSignal TransductionJanus Kinase 2Gene Expression Regulation, NeoplasticCell ProliferationAdenosineCell Line, TumorMethyltransferasesMiceAnimalsPrognosisCell Movement

Substanzen

STAT3 Transcription FactorRNA, CircularInterleukin-6STAT3 protein, humanJAK2 protein, humanJanus Kinase 2N-methyladenosineIL6 protein, humanAdenosineMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. xiaojunchen2009@sina.com.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. xiaojunchen2009@sina.com.
  • Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. docwuxh@hotmail.com.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. docwuxh@hotmail.com.

Förderung

  • National Natural Science Foundation of China (National Science Foundation of China)

Zitieren

APA

Han, X., Xia, L., Wu, Y., Chen, X., & Wu, X. (2025). m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways. Oncogene, 44(14), 968-982. https://doi.org/10.1038/s41388-024-03260-5

Vancouver

Han X, Xia L, Wu Y, Chen X, Wu X. m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways. Oncogene. 2025;44(14):968-982. doi:10.1038/s41388-024-03260-5

BibTeX
@article{Han2025,
  author = {Han, Xiaotian and Xia, Lingfang and Wu, Yong and Chen, Xiaojun and Wu, Xiaohua},
  title = {m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways},
  journal = {Oncogene},
  year = {2025},
  volume = {44},
  number = {14},
  pages = {968--982},
  doi = {10.1038/s41388-024-03260-5}
}
Kostenlos starten →